Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Transmedics Group Inc (NASDAQ: TMDX) closed at $170.17 in the last session, down -3.13% from day before closing price of $175.66. In other words, the price has decreased by -$3.13 from its previous closing price. On the day, 0.64 million shares were traded. TMDX stock price reached its highest trading level at $176.58 during the session, while it also had its lowest trading level at $169.0.
Ratios:
We take a closer look at TMDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.48 and its Current Ratio is at 9.37. In the meantime, Its Debt-to-Equity ratio is 2.72 whereas as Long-Term Debt/Eq ratio is at 2.71.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on August 21, 2024, initiated with a Buy rating and assigned the stock a target price of $208.
On June 06, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $161.
On June 04, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $151.Stephens initiated its Overweight rating on June 04, 2024, with a $151 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Hassanein Waleed H sold 25,000 shares for $175.00 per share. The transaction valued at 4,375,000 led to the insider holds 61,643 shares of the business.
Hassanein Waleed H sold 20,000 shares of TMDX for $3,420,600 on Aug 21 ’24. The President & CEO now owns 61,643 shares after completing the transaction at $171.03 per share. On Aug 21 ’24, another insider, Hassanein Waleed H, who serves as the Officer of the company, bought 45,000 shares for $173.22 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMDX now has a Market Capitalization of 5851993088 and an Enterprise Value of 5830504960. As of this moment, Transmedics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4766.67, and their Forward P/E ratio for the next fiscal year is 92.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.82 while its Price-to-Book (P/B) ratio in mrq is 29.85. Its current Enterprise Value per Revenue stands at 16.252 whereas that against EBITDA is 136.201.
Stock Price History:
Over the past 52 weeks, TMDX has reached a high of $177.37, while it has fallen to a 52-week low of $36.42. The 50-Day Moving Average of the stock is 12.44%, while the 200-Day Moving Average is calculated to be 60.33%.
Shares Statistics:
According to the various share statistics, TMDX traded on average about 753.26K shares per day over the past 3-months and 683470 shares per day over the past 10 days. A total of 32.67M shares are outstanding, with a floating share count of 32.20M. Insiders hold about 3.48% of the company’s shares, while institutions hold 102.84% stake in the company. Shares short for TMDX as of 1722384000 were 5745628 with a Short Ratio of 7.63, compared to 1719532800 on 6001733. Therefore, it implies a Short% of Shares Outstanding of 5745628 and a Short% of Float of 21.01.
